Experts say Trump’s plan to lower drug prices misses mark, unlikely to work

Alan Dow
Experts told Healio Family Medicine that the drug pricing plan presented by President Donald J. Trump to lower drug costs suggests he fails to recognize what is causing high drug prices and consequently, faces an uphill climb in becoming a reality.
On Friday, Trump announced the days of pharmaceutical companies, special interest groups and foreign governments controlling drug pricing are over, and that high drug prices will start to decrease.
As part of the administration’s announcement on drug pricing, HHS released the blueprint for putting the plan into (Read more...)

Full Story →